Person-centered care is a phrase, which seems omnipresent in medical discourse. Can pharmaceutical businesses andindustries be person-centric? This article explores the various facets of person-centered pharmaceutical businesses, it suggestsways of incorporating and measuring person-centricity in the business milieu, and describes best practices shared by leadingpharmaceutical houses.
No takes yet. Share an insight, caveat, or question.
Kalra et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: